Quote:

---

Then why couldn't Cytodyn do a straight-up set of trials for the use of Leronlimab for Cytokine Storm?

---

Money.

NASH is going forward most likely because we have a partner and they'll be revealed once holds are lifted.

If another entity wants to finance more Covid trials, I imagine Cyrus would be onboard, but it doesn't look like that's in the cards.

Hence, no Covid movement for LL.

Crying shame because LL sure seems to work on those cytokines.